Related references
Note: Only part of the references are listed.A Pathogenic Variant Reclassified to the Pseudogene PMS2P1 in a Patient with Suspected Hereditary Cancer
Veronica Fragoso-Ontiveros et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers
Masanori Yoshida et al.
CANCER MEDICINE (2023)
Targeting GNAQ/11 through PKC inhibition in uveal melanoma
Caressa D. Lietman et al.
CANCER GENE THERAPY (2022)
Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome
Christopher J. Schwartz et al.
CLINICAL CANCER RESEARCH (2022)
Rare Hereditary Gynecological Cancer Syndromes
Takafumi Watanabe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The repertoire of germline variants in patients with early-onset rectal cancer
Caroline Moraes Beltrami et al.
CANCER COMMUNICATIONS (2022)
Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center
L. Poliani et al.
ESMO OPEN (2022)
Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer
Thais Baccili Cury Megid et al.
FRONTIERS IN ONCOLOGY (2022)
Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration
Jesica Perez-Garcia et al.
CANCERS (2022)
Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls
Izzet Mehmet Akcay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Reiko Yoshida
BREAST CANCER (2021)
Concurrent pathogenic variations in patients with hereditary cancer syndromes
Nihat Bugra Agaoglu et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2021)
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Jasmine Sukumar et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia
Maroua Boujemaa et al.
PLOS ONE (2021)
Second primary malignancies in colorectal cancer patients
Jana Halamkova et al.
SCIENTIFIC REPORTS (2021)
Disparities in colorectal cancer screening among breast and prostate cancer survivors
Chiranjeev Dash et al.
CANCER MEDICINE (2021)
WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells
Arindam Datta et al.
NATURE COMMUNICATIONS (2021)
DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects
Ondrej Pos et al.
BIOMEDICAL JOURNAL (2021)
Lynch Syndrome-Associated Cancers Beyond Colorectal Cancer
Leah H. Biller et al.
Gastrointestinal Endoscopy Clinics of North America (2021)
Detecting copy number variation in next generation sequencing data from diagnostic gene panels
Ashish Kumar Singh et al.
BMC MEDICAL GENOMICS (2021)
Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas
Douglas Lin et al.
MODERN PATHOLOGY (2021)
Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
Radhakrishnan Vishnubalaji et al.
SCIENTIFIC REPORTS (2021)
WRN Germline Mutation Is the Likely Inherited Etiology of Various Cancer Types in One Iranian Family
Mahnaz Norouzi et al.
FRONTIERS IN ONCOLOGY (2021)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C. Doebele et al.
LANCET ONCOLOGY (2020)
Prognostic value of prostaglandin I2 synthase and its correlation with tumor-infiltrating immune cells in lung cancer, ovarian cancer, and gastric cancer
Danian Dai et al.
AGING-US (2020)
ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription
Kai Zeng et al.
CANCER SCIENCE (2020)
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker
Raul Perret et al.
MODERN PATHOLOGY (2020)
WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype
Kai Zimmer et al.
CANCERS (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
WRN modulates translation by influencing nuclear mRNA export in HeLa cancer cells
Juan Manuel Iglesias-Pedraz et al.
BMC MOLECULAR AND CELL BIOLOGY (2020)
Investigating the Link between Lynch Syndrome and Breast Cancer
Megan Sheehan et al.
EUROPEAN JOURNAL OF BREAST HEALTH (2020)
Identifying patients with NTRK fusion cancer
J. P. Solomon et al.
ANNALS OF ONCOLOGY (2019)
GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer
Wenqian Yu et al.
CELL DEATH & DISEASE (2019)
Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy
Lauren Y. Maldonado et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
The Dystrophin Glycoprotein Complex Regulates the Epigenetic Activation of Muscle Stem Cell Commitment
Natasha C. Chang et al.
CELL STEM CELL (2018)
The changing landscape of Lynch syndrome due to PMS2 mutations
J. Blount et al.
CLINICAL GENETICS (2018)
MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer
Maegan E. Roberts et al.
GENETICS IN MEDICINE (2018)
Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close Homolog
Daniel S. Herman et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
Sebastian M. Waszak et al.
LANCET ONCOLOGY (2018)
Prognosis of ovarian cancer is associated with effector memory CD8(+) T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells
Sonja Lieber et al.
ONCOIMMUNOLOGY (2018)
Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer An Initial Report From the Surveillance, Epidemiology, and End Results Program
Caitlin C. Murphy et al.
JAMA ONCOLOGY (2018)
NFATC2 is a novel therapeutic target for colorectal cancer stem cells
Tingyuan Lang et al.
ONCOTARGETS AND THERAPY (2018)
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
Aung Ko Win et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Whole-exome sequencing identified mutational profiles of high-grade colon adenomas
Sung Hak Lee et al.
ONCOTARGET (2017)
Exomic variants of an elderly cohort of Brazilians in the ABraOM database
Michel Satya Naslavsky et al.
HUMAN MUTATION (2017)
Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development
Rolando A. R. Villacis et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
NOMO-1 gene is deleted in early-onset colorectal cancer
Jose Perea et al.
ONCOTARGET (2017)
Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis
Yang Jiang et al.
THERANOSTICS (2017)
Multiple primary tumours: challenges and approaches, a review
Alexia Vogt et al.
ESMO OPEN (2017)
SIFT missense predictions for genomes
Robert Vaser et al.
NATURE PROTOCOLS (2016)
ROBO1 deletion as a novel germline alteration in breast and colorectal cancer patients
Rolando A. R. Villacis et al.
TUMOR BIOLOGY (2016)
Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer
Daniel Chubb et al.
NATURE COMMUNICATIONS (2016)
NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
Alessio Amatu et al.
ESMO OPEN (2016)
Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas
Isabel Spier et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters
S. K. Mungamuri et al.
ONCOGENE (2015)
A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of Cancer
Liu Yang et al.
PLOS ONE (2015)
circlize implements and enhances circular visualization in R
Zuguang Gu et al.
BIOINFORMATICS (2014)
Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
Felipe C. Silva et al.
BMC MEDICAL GENETICS (2014)
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
C. M. Phelan et al.
BRITISH JOURNAL OF CANCER (2014)
Absent, Small or Homeotic 2-like Protein (ASH2L) Enhances the Transcription of the Estrogen Receptor α Gene through GATA-binding Protein 3 (GATA3)
Jin Qi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
MutationTaster2: mutation prediction for the deep-sequencing age
Jana Marie Schwarz et al.
NATURE METHODS (2014)
Li-Fraumeni syndrome: cancer risk assessment and clinical management
Kate A. McBride et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Association between CYP1A2 and CYP1B1 Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis
Xiao-Feng He et al.
PLOS ONE (2014)
Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models
Hashem A. Shihab et al.
HUMAN MUTATION (2013)
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis
Maddalena Frau et al.
JOURNAL OF HEPATOLOGY (2013)
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
Claire Palles et al.
NATURE GENETICS (2013)
Overexpression of PTGIS Could Predict Liver Metastasis and is Correlated with Poor Prognosis in Colon Cancer Patients
Sun Lichao et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression Network
Katri Pylkas et al.
PLOS GENETICS (2012)
Germline DNA copy number variation in familial and early-onset breast cancer
Ana C. V. Krepischi et al.
BREAST CANCER RESEARCH (2012)
Avoidance of Pseudogene Interference in the Detection of 3′ Deletions in PMS2
Cecily P. Vaughn et al.
HUMAN MUTATION (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar et al.
NATURE PROTOCOLS (2009)
Getting rid of the PMS2 pseudogenes: Mission impossible?
Renee C. Niessen et al.
HUMAN MUTATION (2007)
Inherited association of breast and colorectal cancer:: limited role of CHEK2 compared with high-penetrance genes
H. Naseem et al.
CLINICAL GENETICS (2006)
Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy
J Frigola et al.
ONCOGENE (2005)
Primary malignancy after primary female breast cancer in the south of the Netherlands, 1972-2001
I Soerjomataram et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype
H Meijers-Heijboer et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Share Paper
